Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study

PurposeWe studied the association between parathormone (PTH) levels and long-term graft loss in RTx patients (RTx-p).MethodsWe retrospectively evaluated 871 RTx-p, transplanted in our unit from Jan-2004 to Dec-2020 assessing renal function and mineral metabolism parameters at 1, 6, and 12 months aft...

Full description

Bibliographic Details
Main Authors: Paolo Molinari, Anna Regalia, Alessandro Leoni, Mariarosaria Campise, Donata Cresseri, Elisa Cicero, Simone Vettoretti, Luca Nardelli, Emilietta Brigati, Evaldo Favi, Piergiorgio Messa, Giuseppe Castellano, Carlo M. Alfieri
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1221086/full
_version_ 1827368793279561728
author Paolo Molinari
Paolo Molinari
Anna Regalia
Alessandro Leoni
Mariarosaria Campise
Donata Cresseri
Elisa Cicero
Elisa Cicero
Simone Vettoretti
Luca Nardelli
Emilietta Brigati
Evaldo Favi
Evaldo Favi
Piergiorgio Messa
Giuseppe Castellano
Giuseppe Castellano
Carlo M. Alfieri
Carlo M. Alfieri
author_facet Paolo Molinari
Paolo Molinari
Anna Regalia
Alessandro Leoni
Mariarosaria Campise
Donata Cresseri
Elisa Cicero
Elisa Cicero
Simone Vettoretti
Luca Nardelli
Emilietta Brigati
Evaldo Favi
Evaldo Favi
Piergiorgio Messa
Giuseppe Castellano
Giuseppe Castellano
Carlo M. Alfieri
Carlo M. Alfieri
author_sort Paolo Molinari
collection DOAJ
description PurposeWe studied the association between parathormone (PTH) levels and long-term graft loss in RTx patients (RTx-p).MethodsWe retrospectively evaluated 871 RTx-p, transplanted in our unit from Jan-2004 to Dec-2020 assessing renal function and mineral metabolism parameters at 1, 6, and 12 months after RTx. Graft loss and death with functioning graft during follow-up (FU, 8.3[5.4–11.4] years) were checked.ResultsAt month-1, 79% had HPT, of which 63% with secondary HPT (SHPT) and 16% tertiary HPT (THPT); at month-6, HPT prevalence was 80% of which SHPT 64% and THPT 16%; at month-12 HPT prevalence was 77% of which SHPT 62% and THPT 15%. A strong significant correlation was found between HPT type, PTH levels and graft loss at every time point. Mean PTH exposure remained strongly and independently associated to long term graft loss (OR 3.1 [1.4–7.1], p = 0.008). THPT was independently associated with graft loss at month-1 when compared to HPT absence and at every time point when compared to SHPT. No correlation was found with RTx-p death. Discriminatory analyses identified the best mean PTH cut-off to predict long-term graft loss to be between 88.6 and 89.9 pg/mL (AUC = 0.658). Cox regression analyses highlighted that THPT was strongly associated with shorter long-term graft survival at every time-point considered.ConclusionHigh PTH levels during 1st year of RTx seem to be associated with long term graft loss.
first_indexed 2024-03-08T09:36:52Z
format Article
id doaj.art-7052041e0e4f4f878639b79224dd4742
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-03-08T09:36:52Z
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-7052041e0e4f4f878639b79224dd47422024-01-30T08:05:35ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2023-08-011010.3389/fmed.2023.12210861221086Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort studyPaolo Molinari0Paolo Molinari1Anna Regalia2Alessandro Leoni3Mariarosaria Campise4Donata Cresseri5Elisa Cicero6Elisa Cicero7Simone Vettoretti8Luca Nardelli9Emilietta Brigati10Evaldo Favi11Evaldo Favi12Piergiorgio Messa13Giuseppe Castellano14Giuseppe Castellano15Carlo M. Alfieri16Carlo M. Alfieri17Unit of Nephrology, Dialysis and Kidney Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milan, ItalyPost-Graduate School of Specialization in Nephrology, University of Milano, Milan, ItalyUnit of Nephrology, Dialysis and Kidney Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milan, ItalyUnit of Nephrology, Dialysis and Kidney Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milan, ItalyUnit of Nephrology, Dialysis and Kidney Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milan, ItalyUnit of Nephrology, Dialysis and Kidney Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milan, ItalyUnit of Nephrology, Dialysis and Kidney Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milan, ItalyPost-Graduate School of Specialization in Nephrology, University of Milano, Milan, ItalyUnit of Nephrology, Dialysis and Kidney Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milan, ItalyUnit of Nephrology, Dialysis and Kidney Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milan, ItalyUnit of Nephrology, Dialysis and Kidney Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milan, ItalyDepartment of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, ItalyGeneral Surgery and Kidney Transplantation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, ItalyDepartment of Nephrology, Dialysis and Kidney Transplants, IRCCS Ca’ Granda Foundation Maggiore Policlinico Hospital, Milan, ItalyUnit of Nephrology, Dialysis and Kidney Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milan, ItalyDepartment of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, ItalyUnit of Nephrology, Dialysis and Kidney Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milan, ItalyDepartment of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, ItalyPurposeWe studied the association between parathormone (PTH) levels and long-term graft loss in RTx patients (RTx-p).MethodsWe retrospectively evaluated 871 RTx-p, transplanted in our unit from Jan-2004 to Dec-2020 assessing renal function and mineral metabolism parameters at 1, 6, and 12 months after RTx. Graft loss and death with functioning graft during follow-up (FU, 8.3[5.4–11.4] years) were checked.ResultsAt month-1, 79% had HPT, of which 63% with secondary HPT (SHPT) and 16% tertiary HPT (THPT); at month-6, HPT prevalence was 80% of which SHPT 64% and THPT 16%; at month-12 HPT prevalence was 77% of which SHPT 62% and THPT 15%. A strong significant correlation was found between HPT type, PTH levels and graft loss at every time point. Mean PTH exposure remained strongly and independently associated to long term graft loss (OR 3.1 [1.4–7.1], p = 0.008). THPT was independently associated with graft loss at month-1 when compared to HPT absence and at every time point when compared to SHPT. No correlation was found with RTx-p death. Discriminatory analyses identified the best mean PTH cut-off to predict long-term graft loss to be between 88.6 and 89.9 pg/mL (AUC = 0.658). Cox regression analyses highlighted that THPT was strongly associated with shorter long-term graft survival at every time-point considered.ConclusionHigh PTH levels during 1st year of RTx seem to be associated with long term graft loss.https://www.frontiersin.org/articles/10.3389/fmed.2023.1221086/fullkidney transplantationparathormonehyperparathyroidismtertiary hyperparathyroidismgraft outcome
spellingShingle Paolo Molinari
Paolo Molinari
Anna Regalia
Alessandro Leoni
Mariarosaria Campise
Donata Cresseri
Elisa Cicero
Elisa Cicero
Simone Vettoretti
Luca Nardelli
Emilietta Brigati
Evaldo Favi
Evaldo Favi
Piergiorgio Messa
Giuseppe Castellano
Giuseppe Castellano
Carlo M. Alfieri
Carlo M. Alfieri
Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study
Frontiers in Medicine
kidney transplantation
parathormone
hyperparathyroidism
tertiary hyperparathyroidism
graft outcome
title Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study
title_full Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study
title_fullStr Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study
title_full_unstemmed Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study
title_short Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study
title_sort impact of hyperparathyroidism and its different subtypes on long term graft outcome a single transplant center cohort study
topic kidney transplantation
parathormone
hyperparathyroidism
tertiary hyperparathyroidism
graft outcome
url https://www.frontiersin.org/articles/10.3389/fmed.2023.1221086/full
work_keys_str_mv AT paolomolinari impactofhyperparathyroidismanditsdifferentsubtypesonlongtermgraftoutcomeasingletransplantcentercohortstudy
AT paolomolinari impactofhyperparathyroidismanditsdifferentsubtypesonlongtermgraftoutcomeasingletransplantcentercohortstudy
AT annaregalia impactofhyperparathyroidismanditsdifferentsubtypesonlongtermgraftoutcomeasingletransplantcentercohortstudy
AT alessandroleoni impactofhyperparathyroidismanditsdifferentsubtypesonlongtermgraftoutcomeasingletransplantcentercohortstudy
AT mariarosariacampise impactofhyperparathyroidismanditsdifferentsubtypesonlongtermgraftoutcomeasingletransplantcentercohortstudy
AT donatacresseri impactofhyperparathyroidismanditsdifferentsubtypesonlongtermgraftoutcomeasingletransplantcentercohortstudy
AT elisacicero impactofhyperparathyroidismanditsdifferentsubtypesonlongtermgraftoutcomeasingletransplantcentercohortstudy
AT elisacicero impactofhyperparathyroidismanditsdifferentsubtypesonlongtermgraftoutcomeasingletransplantcentercohortstudy
AT simonevettoretti impactofhyperparathyroidismanditsdifferentsubtypesonlongtermgraftoutcomeasingletransplantcentercohortstudy
AT lucanardelli impactofhyperparathyroidismanditsdifferentsubtypesonlongtermgraftoutcomeasingletransplantcentercohortstudy
AT emiliettabrigati impactofhyperparathyroidismanditsdifferentsubtypesonlongtermgraftoutcomeasingletransplantcentercohortstudy
AT evaldofavi impactofhyperparathyroidismanditsdifferentsubtypesonlongtermgraftoutcomeasingletransplantcentercohortstudy
AT evaldofavi impactofhyperparathyroidismanditsdifferentsubtypesonlongtermgraftoutcomeasingletransplantcentercohortstudy
AT piergiorgiomessa impactofhyperparathyroidismanditsdifferentsubtypesonlongtermgraftoutcomeasingletransplantcentercohortstudy
AT giuseppecastellano impactofhyperparathyroidismanditsdifferentsubtypesonlongtermgraftoutcomeasingletransplantcentercohortstudy
AT giuseppecastellano impactofhyperparathyroidismanditsdifferentsubtypesonlongtermgraftoutcomeasingletransplantcentercohortstudy
AT carlomalfieri impactofhyperparathyroidismanditsdifferentsubtypesonlongtermgraftoutcomeasingletransplantcentercohortstudy
AT carlomalfieri impactofhyperparathyroidismanditsdifferentsubtypesonlongtermgraftoutcomeasingletransplantcentercohortstudy